National Eye Institute

Researchers at the National Institutes of Health applied artificial intelligence (AI) to a technique that produces high-resolution images of cells in the eye. They report that with AI, imaging is 100 times faster and improves image contrast 3.5-fold.

The National Eye Institute (NEI) of the National Institutes of Health (NIH) announces the start of a multicenter clinical trial to compare the relative safety and effectiveness of two drugs currently used to treat advanced age-related macular degeneration (AMD).

A multicenter clinical trial found that patients with AIDS and CMV retinitis treated with foscarnet lived longer than those treated with ganciclovir.

Results from two years of patient followup in a randomized clinical trial suggest that argon laser therapy may be a safe and effective alternative to eyedrops as a first treatment for patients with newly diagnosed open-angle glaucoma.

The page describes NEI’s mission, leadership, impact in vision research, and eye health education efforts to prevent vision loss.

View recent Congressional testimony and budget justifications for the National Eye Institute.

The page describes NEI’s eye health education programs, including NEHEP, campaigns, and outreach tools that help communities promote healthy vision.

The page describes the NEI leadership team, including director Dr. Paul A. Sieving.

NEI provides contact information for staff handling eye health information, media inquiries, and grant application assistance.

The National Eye Institute leads vision research, supports eye health education, and helps people protect and preserve their sight.

GitHubRepository owner